Terms: = Colorectal cancer AND FGFR1, CEK, 2260, ENSG00000077782, P11362, FLT2, CD331, H3, HBGFR, FGFBR, H5, KAL2, H2, BFGFR, N-SAM, H4
772 results:
1. YEATS domain-containing protein GAS41 regulates nuclear shape by working in concert with BRD2 and the mediator complex in colorectal cancer.
Wang Z; Zhao N; Zhang S; Wang D; Wang S; Liu N
Pharmacol Res; 2024 Aug; 206():107283. PubMed ID: 38964523
[TBL] [Abstract] [Full Text] [Related]
2. Novel 1,3,4-oxadiazole derivatives of naproxen targeting EGFR: Synthesis, molecular docking studies, and cytotoxic evaluation.
Alsaad HN; Al-Jasani BM; Mahmood AAR; Tahtamouni LH; Saleh KM; AlSakhen MF; Kanaan SI; Yasin SR
Drug Dev Res; 2024 Aug; 85(5):e22231. PubMed ID: 38956926
[TBL] [Abstract] [Full Text] [Related]
3. Comprehensive genomic profiling and therapeutic implications for Taiwanese patients with treatment-naïve breast cancer.
Chen SH; Tse KP; Lu YJ; Chen SJ; Tian YF; Tan KT; Li CF
Cancer Med; 2024 Jun; 13(12):e7384. PubMed ID: 38895905
[TBL] [Abstract] [Full Text] [Related]
4. Chemical Proteomic Profiling of Protein Dopaminylation in colorectal cancer Cells.
Zhang N; Gao S; Peng H; Wu J; Li H; Gibson C; Wu S; Zhu J; Zheng Q
J Proteome Res; 2024 Jul; 23(7):2651-2660. PubMed ID: 38838187
[TBL] [Abstract] [Full Text] [Related]
5. [Expression characteristics and clinical significance of B7-H3 in colorectal cancer].
Shao Y; Shi T; Guo L; Chen W
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2024 May; 40(5):435-442. PubMed ID: 38790100
[TBL] [Abstract] [Full Text] [Related]
6. Potential drug targets for tumors identified through Mendelian randomization analysis.
Song N; Shi P; Cui K; Zeng L; Wang Z; Di W; Li J; Fan Y; Li Z; Zhang J; Su W; Wang H
Sci Rep; 2024 May; 14(1):11370. PubMed ID: 38762700
[TBL] [Abstract] [Full Text] [Related]
7. AURKB promotes colorectal cancer progression by triggering the phosphorylation of histone H3 at serine 10 to activate CCNE1 expression.
Li L; Xie K; Xie H; Wang L; Li Z; Lu Q; Feng J
Aging (Albany NY); 2024 May; 16(9):8019-8030. PubMed ID: 38713155
[TBL] [Abstract] [Full Text] [Related]
8. Risk of cancer in patients with bile acid diarrhoea: a Danish nationwide matched cohort study.
Nyboe Andersen N; Wildt S; Iversen AT; Poulsen G; Jess T; Munck LK; Borup C
BMJ Open Gastroenterol; 2024 Apr; 11(1):. PubMed ID: 38688717
[TBL] [Abstract] [Full Text] [Related]
9. Morphological Changes Induced by TKS4 Deficiency Can Be Reversed by EZH2 Inhibition in colorectal Carcinoma Cells.
Jacksi M; Schad E; Tantos A
Biomolecules; 2024 Apr; 14(4):. PubMed ID: 38672463
[TBL] [Abstract] [Full Text] [Related]
10. Targeting fgfr1 by β,β-dimethylacrylalkannin suppresses the proliferation of colorectal cancer in cellular and xenograft models.
Zhao R; Yin F; Fredimoses M; Zhao J; Fu X; Xu B; Liang M; Chen H; Liu K; Lei M; Laster KV; Li Z; Kundu JK; Dong Z; Lee MH
Phytomedicine; 2024 Jul; 129():155612. PubMed ID: 38669968
[TBL] [Abstract] [Full Text] [Related]
11. B7-H3 Expression in Breast cancer and Brain Metastasis.
Joshi V; Beecher K; Lim M; Stacey A; Feng Y; Jat PS; Duijf PHG; Simpson PT; Lakhani SR; McCart Reed AE
Int J Mol Sci; 2024 Apr; 25(7):. PubMed ID: 38612786
[TBL] [Abstract] [Full Text] [Related]
12. Cimetidine repurposed as a potential immunomodulatory agent against colorectal carcinoma: A systematic review.
Gunasekara W; Sachindra J; Madhushika MT; Liyanage P; Lekamwasam S
J Oncol Pharm Pract; 2024 Jul; 30(5):930-936. PubMed ID: 38592456
[TBL] [Abstract] [Full Text] [Related]
13. Fruquintinib as new treatment option in metastatic colorectal cancer patients: is there an optimal sequence?
Stucchi E; Bartolini M; Airoldi M; Fazio R; Daprà V; Mondello G; Prete MG; Puccini A; Santoro A
Expert Opin Pharmacother; 2024 Mar; 25(4):371-382. PubMed ID: 38568032
[TBL] [Abstract] [Full Text] [Related]
14. Circular RNA circTATDN3 promotes the Warburg effect and proliferation in colorectal cancer.
Lin J; Zhong W; Lyu Z; Peng J; Rong Y; Zeng K; Lai J; Wu D; Wang J; Li Y; Zheng J; Zhang J; Pan Z
Cancer Lett; 2024 May; 589():216825. PubMed ID: 38548218
[TBL] [Abstract] [Full Text] [Related]
15. Select EZH2 inhibitors enhance viral mimicry effects of DNMT inhibition through a mechanism involving NFAT:AP-1 signaling.
Chomiak AA; Tiedemann RL; Liu Y; Kong X; Cui Y; Wiseman AK; Thurlow KE; Cornett EM; Topper MJ; Baylin SB; Rothbart SB
Sci Adv; 2024 Mar; 10(13):eadk4423. PubMed ID: 38536911
[TBL] [Abstract] [Full Text] [Related]
16. Uracil- and Pyridine-Containing HDAC Inhibitors Displayed Cytotoxicity in colorectal and Glioblastoma cancer Stem Cells.
Fiorentino F; Fabbrizi E; Raucci A; Noce B; Fioravanti R; Valente S; Paolini C; De Maria R; Steinkühler C; Gallinari P; Rotili D; Mai A
ChemMedChem; 2024 Jul; 19(13):e202300655. PubMed ID: 38529661
[TBL] [Abstract] [Full Text] [Related]
17. Use of tryptic peptide MALDI mass spectrometry imaging to identify the spatial proteomic landscape of colorectal cancer liver metastases.
Li CMY; Briggs MT; Lee YR; Tin T; Young C; Pierides J; Kaur G; Drew P; Maddern GJ; Hoffmann P; Klingler-Hoffmann M; Fenix K
Clin Exp Med; 2024 Mar; 24(1):53. PubMed ID: 38492056
[TBL] [Abstract] [Full Text] [Related]
18. Management of acute and chronic pelvic sepsis after total mesorectal excision for rectal cancer-a 10-year experience of a national referral centre.
Sharabiany S; Joosten JJ; Musters GD; Talboom K; Tanis PJ; Bemelman WA; Hompes R
Colorectal Dis; 2024 Apr; 26(4):650-659. PubMed ID: 38418896
[TBL] [Abstract] [Full Text] [Related]
19. Synergic actions of botulinum neurotoxin A and oxaliplatin on colorectal tumour cell death through the upregulation of TRPM2 channel-mediated oxidative stress.
Demir S; Duman İ; Nazıroğlu M
Clin Exp Pharmacol Physiol; 2024 Apr; 51(4):e13844. PubMed ID: 38350599
[TBL] [Abstract] [Full Text] [Related]
20. Cost-effectiveness of pembrolizumab for previously treated MSI-H/dMMR solid tumours in the UK.
McCarthy G; Young K; Madin-Warburton M; Mantaian T; Brook E; Metcalfe K; Mikelson J; Xu R; Seyla-Hammer C; Aguiar-Ibáñez R; Amonkar M
J Med Econ; 2024; 27(1):279-291. PubMed ID: 38293714
[TBL] [Abstract] [Full Text] [Related]
[Next]
